Clinical Trials Logo

Filter by:
NCT ID: NCT04672837 Recruiting - Clinical trials for Congenital Muscular Torticollis

Pediatric Integrative Manual Therapy in Babies With Deformational Plagiocephaly and Congenital Muscular Torticollis

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of Pediatric Integrative Manual Therapy in the treatment of positional plagiocephaly in infants. 25 participants will receive a protocol of Pediatric Integrative Manual Therapy and educational physiotherapy in combination, while the other 25 will receive a stretching protocol and educational physiotherapy

NCT ID: NCT04670393 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Antioxidant Supplement Associated With Oral Probiotics in Patients With PCOS in IVF

Start date: December 2, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to study the effect of an antioxidant food supplement associated with probiotics on the oocyte quality response, oxidative stress and microbiota function in an in vitro fertilization cycle in patients with polycystic ovarian syndrome

NCT ID: NCT04670172 Recruiting - Clinical trials for Chronic Rhinosinusitis (Diagnosis)

Real-Life Chronic Rhinosinusitis Outcome Registry

Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

An international consortium of leading medical experts in the field of chronic respiratory disease, the research team of Galenus Health and the non-profit organization EUFOREA (European Forum for Research and Education in Allergy and Airway diseases) has been conceived to conduct real-life outcome research. The Galenus Health digital platform consisting of a mobile application for patients and an online dashboard for physicians will be implemented in each of the participating centres. The data will be centralized in a pseudonymized database and will be the basis of the Chronic RhinoSinusitis Outcome Registry.

NCT ID: NCT04669171 Recruiting - Follicular Lymphoma Clinical Trials

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

SIDNEY
Start date: July 5, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to define the recommended Phase 2 Dose, safety, tolerability, immunogenicity, and preliminary efficacy of EO2463 during monotherapy and in combination with lenalidomide and/or rituximab in patients with indolent NHL

NCT ID: NCT04668963 Recruiting - Clinical trials for Hemiplegia, Post-Ictal

Mirror Therapy in Older Adults Post-stroke

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Objective: The present work was carried out to determine the effectiveness of neuromuscular stimulation triggered by mirror therapy in older patients with post-stroke hemiplegia by two different intervention protocols, either intensively or spaced over time. Design: Prospective longitudinal study Setting: Two Spanish rehabilitation centres. Participants: forty four aging patients (>70 y) with diagnosed post-stroke hemiplegia were randomly distributed to intensive intervention group (5 times/week for 6 weeks), or to spaced intervention group (3 times/week for 10 weeks) which were underwent to similar number of mirror therapy sessions (n=30). Main outcome measures: Muscle strength and activity was measured at baseline and at the end of treatment. Functional ability was also evaluated.

NCT ID: NCT04668716 Recruiting - Clinical trials for Duchenne Muscular Dystrophy

Brain Involvement in Dystrophinopathies Part 2

Start date: October 11, 2021
Phase:
Study type: Observational

The objective of this study is to understand the relationship between DMD and BMD brain comorbidities, and the location of the gene mutation which causes the disease.

NCT ID: NCT04666610 Recruiting - Clinical trials for Childhood Absence Epilepsy

A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

EXPAND
Start date: July 29, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to test the efficacy, safety and tolerability of brivaracetam monotherapy in study participants 2 to 25 years of age inclusive with childhood absence epilepsy (CAE) or juvenile absence epilepsy (JAE).

NCT ID: NCT04666116 Recruiting - COVID-19 Clinical Trials

Changes in Viral Load in COVID-19 After Probiotics

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The main objective of the study is to evaluate the capacity of a novel nutritional supplement intervention including strains from the species Bifidobacterium longum, Bifidobacterium animalis subsp. Lactis and Lactobacillus rhamnosus, plus vitamin D, zinc and seleniumt) (immune system enhancer, antioxidant and anti-inflammatory capacity) to decrease the viral load by nasopharyngeal smear in patients admitted for COVID-19 coronavirus disease.

NCT ID: NCT04665141 Recruiting - Asthma Clinical Trials

Similarities and Differences of Biological Therapies for Severe Asthma.

Start date: April 7, 2021
Phase:
Study type: Observational

This is an ambispective multicenter longitudinal observational study to evaluate the efficacy and safety profile of biological therapies in patients diagnosed with severe asthma in real life conditions.

NCT ID: NCT04663893 Recruiting - Clinical trials for Periprosthetic Fractures

Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis

PIPPAS
Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

This study supports Spanish data collection and analysis on Periprosthetic and Peri-implant fractures of the upper and lower limb. Treatment and clinical management of this fractures are complex and goes along with complications. There will be more than 70 hospitals providing information. This study will provide evidence on which is the best treatment for every unique patient. This will help trauma surgeons and geriatricians to provide better treatments, to improve health care in our society, reducing mortality, morbidity, improving functional outcomes, and reducing costs, which in turn will be advances in trauma care.